Home / Market News / $AMS

$AMS news and market catalysts

The 6 most recent market catalysts affecting $AMS, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.

6 catalysts 2 high impact 3 bullish 3 bearish Technology
Nov 16, 2026 Corporate Catalyst Bearish Impact 65
Kepler Cheuvreux Lowers Price Target for ams-OSRAM
Kepler Cheuvreux's decision to lower its price target for ams-OSRAM directly impacted the company's share price, causing a 2.6% decline. This analyst downgrade signals a potential …
Nov 13, 2026 Corporate Catalyst Bullish Impact 85
American Shared Hospital Services Reports Third Quarter and Nine-Month 2026 Financial Results
American Shared Hospital Services (AMS) reported a net loss of $620,000 in Q3 2026, a substantial increase from the $17,000 loss in Q3 2025. This wider loss is a key concern for in…
Nov 13, 2026 Corporate Catalyst Bearish Impact 75
AMS Osram Reports Q3 2026 Financial Results
AMS Osram's Q3 2026 results show a mixed picture: while revenue slightly beat expectations, operational performance saw a decline in adjusted EBITDA and a 3% revenue decrease year-…
Nov 12, 2026 Corporate Catalyst Bullish Impact 55
American Shared Hospital Services Announces Third Quarter 2026 Financial Results and Financing Update
American Shared Hospital Services (AMS) released its third-quarter 2026 financial results, which is a routine disclosure for publicly traded companies. The more significant news wi…
Nov 9, 2026 Corporate Catalyst Bullish Impact 55
Advanced Medical Solutions Group plc Announces Preferred Partnership with NAMSA
Advanced Medical Solutions Group plc (AMS) has entered into a preferred partnership with NAMSA, a medical research and regulatory services provider. This collaboration is significa…
Aug 13, 2026 Corporate Catalyst Bearish Impact 85
American Shared Hospital Q2 EPS $(0.07) Misses $(0.02) Estimate, Sales $8.430M Beat $7.560M Estimate
American Shared Hospital (AMS) reported a significant miss on its Q2 EPS, coming in at $(0.07) against an estimate of $(0.02), representing a 250% miss and a 75% decrease from the …
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.